Douglas Wallace

34PUBLICATIONS

196CO-AUTHORS

Metabolic medicineMolecular targetsMedical devicesMedical infection agents (incl. prions)Electrical energy generation (incl. renewables, excl. photovoltaics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (34)

Sort by Publication Date:

|Jun 18, 2026

Mitochondrial cardiomyopathy: bridging molecular mechanisms and clinical frontiers.

|Jun 03, 2026

Mitochondrial OXPHOS restricts SARS-CoV-2 replication.

|May 06, 2026

Author Correction: Partial restoration of mitochondrial dysfunction by AAV-Ant1 protects from dilated cardiomyopathy in Ant1<sup>-/-</sup> plus mtDNA mutant mice.

|Dec 15, 2025

Partial restoration of mitochondrial dysfunction by AAV-Ant1 protects from dilated cardiomyopathy in Ant1<sup>-/-</sup> plus mtDNA mutant mice.

Alessia Angelin, Kierstin Keller, Peiran Lu

|Dec 15, 2025

Combined ketone body and glutamine supplementation restores aerobic energy production in AGC1-deficient neuronal progenitors.

Simona Nicole Barile, Maria Chiara Magnifico, Eleonora Poeta

|Oct 15, 2025

Importance of De Novo Gene Evolution to Emerging Viral Threats: The ORF10 Strain-Restricted Orphan Gene of SARS-CoV-2 Promotes Pathogenesis.

Jeffrey A Haltom, Nidia S Trovao, Joseph W Guarnieri

Pageof 6

Frequent Collaborators

Afshin Beheshti

Stephen B Baylin

Larry N Singh

Alessia Angelin

Deborah G Murdock

Viktorija Zaksas

Christopher E Mason

Zimu Cen

Eve Syrkin Wurtele

Francisco J Enguita

Frequent Collaborators

Afshin Beheshti

Stephen B Baylin

Larry N Singh

Alessia Angelin